CD146: a potential therapeutic target for systemic sclerosis

References

[1] Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P (2012) Activation of canonical Wnt signalling is required for TGFbeta-mediated fibrosis. Nat Commun 3:735

[2] Bergmann C, Distler JH (2016) Canonical Wnt signaling in systemic sclerosis. Lab Invest 96:151–155

[3] Bhattacharyya S, Wei J, Varga J (2012) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8:42–54

[4] Dagur PK, McCoy JP, Jr (2015) Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases. Autoimmun Rev 14:415–22.

[5] Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma-current concepts and novel targets for therapy. Semin Immunopathol 38:87–95

[6] Duan H, Xing S, Luo Y, Feng L, Gramaglia I (2013) Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. Sci Rep 3:1687

[7] Ito T, Tamura N, Okuda S, Tada K, Matsushita M, Yamaji K (2017) Elevated serum levels of soluble CD146 in patients with systemic sclerosis. Clin Rheumatol 36:119–124

[8] Kaspi E, Heim X, Granel B, Guillet B, Stalin J (2017) Identification of CD146 as a novel molecular actor involved in systemic sclerosis. J Allergy Clin Immunol 5:1448–1451

[9] Katsumoto TR, Whitfield ML, Connolly MK (2011) The pathogenesis of systemic sclerosis. Annu Rev Pathol 6:509–537

[10] Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G (1987) Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:841–845

[11] Liu WF, Ji SR, Sun JJ, Zhang Y, Liu ZY (2012) CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer. Int J Mol Sci 13:6399–6406

[12] Luo Y, Duan H, Qian Y, Feng L, Wu Z (2017) Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Cell Res 27:352–372

[13] Tung HH, Lee SL (2017) Physical Binding of Endothelial MCAM and Neural Transmembrane Protease Matriptase-Novel Cell Adhesion in Neural Stem cell Vascular Niche. Sci Rep 7:4946

[14] Xing S, Luo Y, Liu Z, Bu P, Duan H, (2014) Targeting endothelial CD146 attenuates colitis and prevents colitis-associated carcinogenesis. Am J Pathol 184:1604–1616

[15] Zheng C, Qiu Y, Zeng Q, Zhang Y, Lu D (2009) Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J Biochem Cell Biol 41:2163–2172

RIGHTS & PERMISSIONS

The Author(s) 2018